Загрузка...
Chk’ing p53-deficient breast cancers
Loss or functional impairment of p53 occurs in many human cancers, and its absence is often associated with a poor response to conventional chemotherapy. Hence, much effort is currently devoted to developing novel treatments for p53-deficient malignancies. One approach is to target pathways that are...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3314482/ https://ncbi.nlm.nih.gov/pubmed/22446183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI63205 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|